We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$638M
AUM Growth
+$37.5M
Cap. Flow
-$628K
Cap. Flow %
-0.1%
Top 10 Hldgs %
26.89%
Holding
248
New
15
Increased
94
Reduced
104
Closed
9

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.44M
2
LDOS icon
Leidos
LDOS
+$3.34M
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$1.15M
4
META icon
Meta Platforms (Facebook)
META
+$453K
5
IWB icon
iShares Russell 1000 ETF
IWB
+$287K

Top Sells

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$2.99M
2
NWSA
NEWS CORPORATION CL-A
NWSA
+$1.1M
3
RS icon
Reliance Steel & Aluminium
RS
+$1.1M
4
QCOM icon
Qualcomm
QCOM
+$537K
5
IJT icon
iShares S&P Small-Cap 600 Growth ETF
IJT
+$326K

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.6%
2 Healthcare 13.6%
3 Consumer Staples 11.74%
4 Technology 10.54%
5 Financials 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTU icon
151
Intuit
INTU
$97.9B
$809K 0.13%
12,195
-185
-1% -$11.9K
MDY icon
152
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
$777K 0.12%
3,434
-85
-2% -$18.9K
IJR icon
153
iShares Core S&P Small-Cap ETF
IJR
$110B
$771K 0.12%
15,452
+778
+5% +$37.6K
SYK icon
154
Stryker
SYK
$127B
$767K 0.12%
11,355
-95
-0.8% -$6.56K
DVN icon
155
Devon Energy
DVN
$52.1B
$754K 0.12%
13,055
-610
-4% -$34.8K
VCR icon
156
Vanguard Consumer Discretionary ETF
VCR
$6.04B
$745K 0.12%
7,535
-66
-0.9% -$6.34K
VZ icon
157
Verizon
VZ
$208B
$737K 0.12%
15,795
+299
+2% +$14.6K
DELL
158
DELISTED
DELL INC
DELL
$734K 0.12%
53,399
-2,815
-5% -$38.1K
SU icon
159
Suncor Energy
SU
$76.5B
$718K 0.11%
20,063
-4,874
-20% -$162K
VBK icon
160
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24B
$704K 0.11%
6,150
-45
-0.7% -$4.97K
MPC icon
161
Marathon Petroleum
MPC
$104B
$688K 0.11%
21,396
-1,000
-4% -$35.2K
MON
162
DELISTED
Monsanto Co
MON
$645K 0.1%
6,177
-1,350
-18% -$136K
WFM
163
DELISTED
Whole Foods Market Inc
WFM
$628K 0.1%
10,736
-1,410
-12% -$77.8K
ELV icon
164
Elevance Health
ELV
$85.5B
$610K 0.1%
7,290
-765
-9% -$65.6K
COF icon
165
Capital One
COF
$132B
$599K 0.09%
8,718
+1,078
+14% +$72.5K
NBIX icon
166
Neurocrine Biosciences
NBIX
$15.7B
$599K 0.09%
52,957
– –
VUG icon
167
Vanguard Morningstar Growth ETF
VUG
$228B
$596K 0.09%
42,252
-780
-2% -$10.7K
BIIB icon
168
Biogen
BIIB
$32.3B
$592K 0.09%
2,460
+176
+8% +$39.4K
VSS icon
169
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12.1B
$591K 0.09%
5,949
+75
+1% +$7.16K
WDFC icon
170
WD-40
WDFC
$2.91B
$561K 0.09%
8,644
– –
GRFS
171
Grifois
GRFS
$5.23B
$554K 0.09%
36,622
– –
VIS icon
172
Vanguard Industrials ETF
VIS
$8.07B
$552K 0.09%
6,175
-33
-0.5% -$2.86K
CMCSK
173
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$544K 0.09%
12,553
-60
-0.5% -$2.6K
IVW icon
174
iShares S&P 500 Growth ETF
IVW
$76.8B
$516K 0.08%
23,096
+4,228
+22% +$93.3K
F icon
175
Ford
F
$55.3B
$515K 0.08%
30,538
+10,719
+54% +$181K
5 6
7
8 9

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
CCM
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q3 2013 Portfolio in Review

As of Q3 2013, Dowling & Yahnke held 248 positions worth $638M, up 6.2% from $601M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Dowling & Yahnke's Q3 2013 filing shows 15 new, 94 increased, 104 reduced and 9 closed positions. Its largest new stake was Pfizer: 199,922 shares worth $5.45M. The largest sale was Ionis Pharmaceuticals, an estimated $2.99M.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Dowling & Yahnke's largest Q3 2013 buy was Pfizer: 199,922 shares worth $5.45M.
  • Dowling & Yahnke added most to Leidos in Q3 2013, an estimated $3.34M increase.
  • Dowling & Yahnke's biggest Q3 2013 reduction was Ionis Pharmaceuticals, cutting an estimated $2.99M.
  • Dowling & Yahnke fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $1.1M.
  • Dowling & Yahnke's ten largest holdings make up 27% of its $638M portfolio in Q3 2013.
  • Dowling & Yahnke opened 15 new positions and closed 9 in Q3 2013.
  • Dowling & Yahnke's portfolio value rose 6.2% quarter-over-quarter to $638M.

Based on Dowling & Yahnke's 13F filing for Q3 2013, filed 12 Nov 2013.